• Home
  • NEW DAY MEDICINE
  • 7(45)2022
  • 75 -7 (45) 2022 — Kenjaev S. R. — INFLUENCE OF DIFFERENT REPERFUSION STRATEGIES ON MYOCARDIAL STUNNING AND LEFT VENTRICULAR REMODELING PARAMETERS IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION

75 -7 (45) 2022 — Kenjaev S. R. — INFLUENCE OF DIFFERENT REPERFUSION STRATEGIES ON MYOCARDIAL STUNNING AND LEFT VENTRICULAR REMODELING PARAMETERS IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION

INFLUENCE OF DIFFERENT REPERFUSION STRATEGIES ON MYOCARDIAL STUNNING AND LEFT VENTRICULAR REMODELING PARAMETERS IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION

Kenjaev S. R. Republican Scientific Center of Emergency Medicine. Tashkent. Uzbekistan

Resume

The aim of the study: To evaluate the impact of the results of different strategies for myocardial revascularization (TLT, PCI and CABG) on clinical and echocardiographic parameters in ST-segment elevation myocardial infarction (STeMI).

Material and methods: The study included 302 patients with STeMI admitted to the intensive care unit cardioterapevtik department of RRCEM.

Results: The use of PCI or thrombolytic therapy followed by PCI are beneficial to the recovery of reversible myocardial stunning dysfunctional areas and indicators of global, regional left ventricular systolic function and left ventricular remodeling than isolated application TLT without subsequent PCI. STeMI patients undergoing thrombolytic therapy, coronary angiography is necessary to conduct delayed to select the method of complete myocardial revascularization (PCI or CABG). CABG 2 months after MI resulted in the recovery of contractile function in the areas of reversible left ventricular disfunction (stunning) and resulted in a decrease in left ventricular zone asinergy and improved clinical performance.

Keywords: stunning, left ventricular remodeling, systemic thrombolysis, primary PCI, coronary artery bypass grafting

First page

396

Last page

401

For citation: Kenjaev S. R. INFLUENCE OF DIFFERENT REPERFUSION STRATEGIES ON MYOCARDIAL STUNNING AND LEFT VENTRICULAR REMODELING PARAMETERS IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION //New Day in Medicine 7(45)2022 396-401 https://clck.ru/sRyUf

LIST OF REFERENCES:

  1. Borja Ibanez, Stefan James, Stefan Agewall, Manuel J Antunes, Chiara Bucciarelli-Ducci, Héctor Bueno, Alida L P Caforio, Filippo Crea, John A Goudevenos, Sigrun Halvorsen, Gerhard Hindricks, Adnan Kastrati, Mattie J Lenzen, Eva Prescott, Marco Roffi, Marco Valgimigli, Christoph Varenhorst, Pascal Vranckx, Petr Widimský, ESC Scientific Document Group, 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC), European Heart Journal, Volume 39, Issue 2, 07 January 2018, Pages 119–177, https://doi.org/10.1093/eurheartj/ehx393
  2. Neumann F‐J., Sousa‐Uva M., Ahlsson A., Alfonso F., Banning A.P., Benedetto U., Byrne R.A., Collet J‐P., Falk V., Head S.J., et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. EuroIntervention. 2019; 14:1435–1534. doi: 10.4244/EIJY19M01_01.
  3. Alyavi A.L., Alyavi B.A. Reperfusion therapy in acute coronary syndrome with ST segment elevation. Rational Pharmacotherapy in Cardiology. 2009;5(3):46-50. (In Russ.) https://doi.org/10.20996/1819-6446-2009-5-3-46-50
  4. Ryabov V.V. Effect of reperfusion therapy and cellular cardiomyoplasty on the structural functional changes in the heart, clinical course and long-term outcomes in patients with acute primary transmural anterior myocardial infarction: / Abstract of the thesis. dis. … Dr. med. Sciences. Tomsk 2009.
  5. Sevastyanova D.S., Markov V.A., Vyshlov E.V. Myocardial reperfusion strategy: pharmaco-invasive revascularization or primary angioplasty in acute coronary syndrome with ST elevation. Research Foundation 2013; 9(4): 729-33.
  6. Brodie B.R., Stuckey T.D., Hansen C. et al. Benefit of coronary reperfusion before intervention on outcomes after primary angioplasty for acute myocardial infarction. // Amer J Cardiol 2000; 85:13-18.
  7. Ellis S.G. The Facilitated Intervention with Enhanced Reperfusion Speed ​​to Stop Events (FINESSE) trial. Presented at the European Society of Cardiology Annual Congress, Vienna, 1-5, 2007.
  8. Keeley E.C., Boura J.A., Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomized trials. Lancet 2003; 361:13-20.
  9. McNamara R.L., Wang Y., Harrin J. et al. Effect of door-to balloon time on mortality in patients with ST-segment elevation myocardial infarction. // J Amer Coll Cardiol 2006; 47:2180-6.
  10. Stone G.W., Cox D., Garcia E. et al. Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in- myocardial infarction trials. Circulation 2001; 104:636-41.
  11. Van de Werf F., Ardissino D., Betriu A. et al. Management of acute myocardial infarction in patients pre-senting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Europ Heart J 2003; 24:28-66.
  12. Weir R.A., Mc Murray J.J., Velazquez E.J. Epidemiology of heart failure and left ventricular systolic dysfunction after acute myocardial infarction: prevalence, clinical characteristics, and prognostic importance. Amer J Cardiol 2006; 97(10A): 13F-25F.
  13. Kenjaev S.R., Boltayev E.B., Comparative analysis of methods for diagnosing myocardial stunning after myocardial infarction //New Day in Medicine 7(45)2022 236-243 https://l.clck.bar/44ae3

file

download